IL18 not only promotes atherosclerosis progression through IFN-γ-dependent inflammation within the lesion of animal models but may also trigger other pro-inflammatory functions independent of Th1 response including priming of human neutrophils for free radical production, cardiac depressant effects and contractile dysfunction. This evidence concerns the gene IL18 and atherosclerosis.